Portage Biotech Alpha and Beta Analysis
| PRTGDelisted Stock | USD 6.08 0.54 9.75% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Portage Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Portage Biotech over a specified time horizon. Remember, high Portage Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Portage Biotech's market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Portage |
Portage Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Portage Biotech market risk premium is the additional return an investor will receive from holding Portage Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Portage Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Portage Biotech's performance over market.| α | 0.00 | β | 0.00 |
Portage Biotech Fundamentals Vs Peers
Comparing Portage Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Portage Biotech's direct or indirect competition across all of the common fundamentals between Portage Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Portage Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Portage Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Portage Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Portage Biotech to competition |
| Fundamentals | Portage Biotech | Peer Average |
| Return On Equity | -5.42 | -0.31 |
| Return On Asset | -0.93 | -0.14 |
| Current Valuation | 9.86 M | 16.62 B |
| Shares Outstanding | 2.28 M | 571.82 M |
| Shares Owned By Insiders | 60.57 % | 10.09 % |
| Shares Owned By Institutions | 4.16 % | 39.21 % |
| Number Of Shares Shorted | 36.16 K | 4.71 M |
Portage Biotech Opportunities
Portage Biotech Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Portage Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Portage or other delisted stocks. Alpha measures the amount that position in Portage Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Portage Biotech Upcoming Company Events
As portrayed in its financial statements, the presentation of Portage Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Portage Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Portage Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Portage Biotech. Please utilize our Beneish M Score to check the likelihood of Portage Biotech's management manipulating its earnings.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 29th of July 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of July 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Portage Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Portage Stock
If you are still planning to invest in Portage Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Portage Biotech's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |